Faze Medicines Appoints Biotech Leader Philip Vickers, Ph.D., as Chief Executive Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced…